{"id":"https://openalex.org/W2511487690","doi":"https://doi.org/10.1089/adt.2016.737","title":"Assessing Drug Efficacy in a Miniaturized Pancreatic Cancer In Vitro 3D Cell Culture Model","display_name":"Assessing Drug Efficacy in a Miniaturized Pancreatic Cancer In Vitro 3D Cell Culture Model","publication_year":2016,"publication_date":"2016-08-23","ids":{"openalex":"https://openalex.org/W2511487690","doi":"https://doi.org/10.1089/adt.2016.737","mag":"2511487690","pmid":"https://pubmed.ncbi.nlm.nih.gov/27552143"},"language":"en","primary_location":{"id":"doi:10.1089/adt.2016.737","doi":"https://doi.org/10.1089/adt.2016.737","is_oa":false,"landing_page_url":"https://doi.org/10.1089/adt.2016.737","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042709613","display_name":"Todd Shelper","orcid":"https://orcid.org/0000-0002-3086-6388","observed_orcids":["https://orcid.org/0000-0002-3086-6388"]},"institutions":[{"id":"https://openalex.org/I11701301","display_name":"Griffith University","ror":"https://ror.org/02sc3r913","country_code":"AU","type":"education","lineage":["https://openalex.org/I11701301"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Todd B. Shelper","raw_affiliation_strings":["Griffith University","Discovery Biology, Eskitis Institute for Drug Discovery, Griffith University, Nathan, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Griffith University","institution_ids":["https://openalex.org/I11701301"]},{"raw_affiliation_string":"Discovery Biology, Eskitis Institute for Drug Discovery, Griffith University, Nathan, Australia","institution_ids":["https://openalex.org/I11701301"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055504613","display_name":"Carrie J. Lovitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I11701301","display_name":"Griffith University","ror":"https://ror.org/02sc3r913","country_code":"AU","type":"education","lineage":["https://openalex.org/I11701301"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Carrie J. Lovitt","raw_affiliation_strings":["Griffith University","Discovery Biology, Eskitis Institute for Drug Discovery, Griffith University, Nathan, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Griffith University","institution_ids":["https://openalex.org/I11701301"]},{"raw_affiliation_string":"Discovery Biology, Eskitis Institute for Drug Discovery, Griffith University, Nathan, Australia","institution_ids":["https://openalex.org/I11701301"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059081442","display_name":"Vicky M. Avery","orcid":"https://orcid.org/0000-0003-4914-2299","observed_orcids":["https://orcid.org/0000-0003-4914-2299","https://orcid.org/0000-0001-8727-7392"]},"institutions":[{"id":"https://openalex.org/I11701301","display_name":"Griffith University","ror":"https://ror.org/02sc3r913","country_code":"AU","type":"education","lineage":["https://openalex.org/I11701301"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Vicky M. Avery","raw_affiliation_strings":["Griffith University","Discovery Biology, Eskitis Institute for Drug Discovery, Griffith University, Nathan, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Griffith University","institution_ids":["https://openalex.org/I11701301"]},{"raw_affiliation_string":"Discovery Biology, Eskitis Institute for Drug Discovery, Griffith University, Nathan, Australia","institution_ids":["https://openalex.org/I11701301"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I11701301"],"apc_list":null,"apc_paid":null,"fwci":2.0128,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.88133239,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"14","issue":"7","first_page":"367","last_page":"380"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11190","display_name":"3D Printing in Biomedical Research","score":0.120899997651577,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.014499999582767487,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/3d-cell-culture","display_name":"3D cell culture","score":0.8709999918937683},{"id":"https://openalex.org/keywords/drug-efficacy-evaluation","display_name":"drug efficacy evaluation","score":0.5669999718666077},{"id":"https://openalex.org/keywords/extracellular-matrix","display_name":"extracellular matrix","score":0.8349999785423279},{"id":"https://openalex.org/keywords/tumor-stroma","display_name":"tumor stroma","score":0.7789999842643738},{"id":"https://openalex.org/keywords/miniaturization","display_name":"miniaturization","score":0.6050000190734863},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.968999981880188},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.7129999995231628},{"id":"https://openalex.org/keywords/cell-viability-assay","display_name":"cell viability assay","score":0.6949999928474426},{"id":"https://openalex.org/keywords/assay-robustness","display_name":"assay robustness","score":0.7789999842643738}],"concepts":[{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.7286825180053711},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.688835620880127},{"id":"https://openalex.org/C163688615","wikidata":"https://www.wikidata.org/wiki/Q15883629","display_name":"3D cell culture","level":3,"score":0.5514437556266785},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5323028564453125},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48304277658462524},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.4757142663002014},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.46872222423553467},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4644593894481659},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.46120092272758484},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.424930214881897},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4248409569263458},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3786145746707916},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.34684479236602783},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33599716424942017},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3193197548389435},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24180257320404053},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.19390782713890076},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.09562543034553528},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07572042942047119},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008904","descriptor_name":"Miniaturization","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018929","descriptor_name":"Cell Culture Techniques","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1089/adt.2016.737","doi":"https://doi.org/10.1089/adt.2016.737","is_oa":false,"landing_page_url":"https://doi.org/10.1089/adt.2016.737","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},{"id":"pmid:27552143","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27552143","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Assay and drug development technologies","raw_type":"Journal Article"},{"id":"pmh:oai:research-repository.griffith.edu.au:10072/100394","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10072/100394","pdf_url":null,"source":{"id":"https://openalex.org/S7407064376","display_name":"Griffith Research Online","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1761753578","https://openalex.org/W1865162173","https://openalex.org/W1962779685","https://openalex.org/W1966551238","https://openalex.org/W1971146759","https://openalex.org/W2007253892","https://openalex.org/W2011244979","https://openalex.org/W2015540146","https://openalex.org/W2020216997","https://openalex.org/W2032672595","https://openalex.org/W2046561846","https://openalex.org/W2054990133","https://openalex.org/W2055106140","https://openalex.org/W2059755711","https://openalex.org/W2073629239","https://openalex.org/W2074705887","https://openalex.org/W2091305528","https://openalex.org/W2101037949","https://openalex.org/W2115124692","https://openalex.org/W2149006989","https://openalex.org/W2149942294","https://openalex.org/W2161884651","https://openalex.org/W2163968551","https://openalex.org/W2168992025","https://openalex.org/W2169895148","https://openalex.org/W2321014869","https://openalex.org/W2399959131","https://openalex.org/W4244578979"],"related_works":["https://openalex.org/W2784763866","https://openalex.org/W3131842571","https://openalex.org/W2149006989","https://openalex.org/W4306923032","https://openalex.org/W3203469850","https://openalex.org/W4282977765","https://openalex.org/W1971146759","https://openalex.org/W4392826321","https://openalex.org/W2396026330","https://openalex.org/W4413449837"],"abstract_inverted_index":{"Pancreatic":[0,102],"cancer":[1,33],"continues":[2],"to":[3,63,88,95],"have":[4,20,46],"one":[5],"of":[6,79,120,130,158,172,181],"the":[7,36,74,99,128,155,209],"poorest":[8],"prognoses":[9],"among":[10],"all":[11],"cancers.":[12],"The":[13],"drug":[14,55,90],"discovery":[15,91],"efforts":[16],"for":[17,30,198],"this":[18],"disease":[19],"largely":[21],"failed,":[22],"with":[23],"no":[24],"significant":[25],"improvement":[26],"in":[27,41,50,138,148,189,201],"survival":[28,135],"outcomes":[29],"advanced":[31],"pancreatic":[32,81,185],"patients":[34],"over":[35],"past":[37],"20":[38],"years.":[39],"Traditional":[40],"vitro":[42],"cell":[43,150,187,194,235],"culture":[44,195],"techniques":[45],"been":[47],"used":[48],"extensively":[49],"both":[51],"basic":[52],"and":[53,77,127,143,183,213,231],"early":[54],"discovery;":[56],"however,":[57],"these":[58],"systems":[59],"offer":[60],"poor":[61],"models":[62],"assess":[64],"emerging":[65],"therapeutics.":[66],"More":[67],"predictive":[68,156],"cell-based":[69],"models,":[70],"which":[71],"better":[72],"capture":[73],"cellular":[75,162],"heterogeneity":[76],"complexities":[78],"solid":[80],"tumors,":[82],"are":[83,104],"urgently":[84],"needed":[85],"not":[86],"only":[87],"improve":[89],"success":[92],"but":[93],"also":[94],"provide":[96],"insight":[97],"into":[98],"tumor":[100,186],"biology.":[101],"tumors":[103],"characterized":[105],"by":[106,113,223],"a":[107,114,159,164,179,190,232],"unique":[108],"micro-environment":[109],"that":[110,211],"is":[111,146],"surrounded":[112],"dense":[115],"stroma.":[116],"A":[117],"complex":[118,161],"network":[119],"interactions":[121],"between":[122],"extracellular":[123],"matrix":[124],"(ECM)":[125],"components":[126],"effects":[129,210],"cell-to-cell":[131],"contacts":[132],"may":[133],"enhance":[134],"pathways":[136],"within":[137],"vivo":[139],"tumors.":[140],"This":[141],"biological":[142],"physical":[144],"complexity":[145],"lost":[147],"traditional":[149],"monolayer":[151],"models.":[152],"To":[153],"explore":[154],"potential":[157,199],"more":[160],"system,":[163],"three-dimensional":[165],"(3D)":[166],"micro-tumor":[167],"assay":[168,217,230],"was":[169,176,205,221],"evaluated.":[170],"Efficacy":[171],"six":[173],"current":[174],"chemotherapeutics":[175],"determined":[177,222],"against":[178],"panel":[180],"primary":[182],"metastatic":[184],"lines":[188],"miniaturized":[191],"ECM-based":[192],"3D":[193],"system.":[196],"Suitability":[197],"use":[200],"high-throughput":[202],"screening":[203],"applications":[204],"assessed,":[206],"including":[207],"ascertaining":[208],"miniaturization":[212],"automation":[214],"had":[215],"on":[216],"robustness.":[218],"Cellular":[219],"health":[220],"utilizing":[224],"an":[225],"indirect":[226],"population-based":[227],"metabolic":[228],"activity":[229],"direct":[233],"imaging-based":[234],"viability":[236],"assay.":[237]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-09-16T00:00:00"}